simple VOTE NO, alone for the fact that entire RAP should be sold, with IP they've been developing for 10 years. Clearly Pfizer is mainly intersted in the Covid Algo, for valid reasons, A: if you're that big simply buy the competition, B: use it as additional revenue stream. So I could understand and consider in selling maybe only the Covid Algo, but why entire firm and IP. This offer is simply a validation of our product and management should beef up their game and take this as confirmation we're heading in the right direction.
- Forums
- ASX - By Stock
- Vote NO Pfizer offer
simple VOTE NO, alone for the fact that entire RAP should be...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online